[go: up one dir, main page]

GB8919102D0 - A recombinant adenovirus dna sequence,a recombinant adenovirus expressing the dna sequence and a rhabdovirus vaccine including the recombinant adenovirus - Google Patents

A recombinant adenovirus dna sequence,a recombinant adenovirus expressing the dna sequence and a rhabdovirus vaccine including the recombinant adenovirus

Info

Publication number
GB8919102D0
GB8919102D0 GB898919102A GB8919102A GB8919102D0 GB 8919102 D0 GB8919102 D0 GB 8919102D0 GB 898919102 A GB898919102 A GB 898919102A GB 8919102 A GB8919102 A GB 8919102A GB 8919102 D0 GB8919102 D0 GB 8919102D0
Authority
GB
United Kingdom
Prior art keywords
recombinant adenovirus
dna sequence
expressing
vaccine including
rhabdovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB898919102A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OXFORD VIROLOGY Ltd
Original Assignee
OXFORD VIROLOGY Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OXFORD VIROLOGY Ltd filed Critical OXFORD VIROLOGY Ltd
Priority to GB898919102A priority Critical patent/GB8919102D0/en
Publication of GB8919102D0 publication Critical patent/GB8919102D0/en
Priority to PCT/GB1990/001217 priority patent/WO1991002804A1/en
Priority to CN90107300.8A priority patent/CN1050561A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB898919102A 1989-08-22 1989-08-22 A recombinant adenovirus dna sequence,a recombinant adenovirus expressing the dna sequence and a rhabdovirus vaccine including the recombinant adenovirus Pending GB8919102D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB898919102A GB8919102D0 (en) 1989-08-22 1989-08-22 A recombinant adenovirus dna sequence,a recombinant adenovirus expressing the dna sequence and a rhabdovirus vaccine including the recombinant adenovirus
PCT/GB1990/001217 WO1991002804A1 (en) 1989-08-22 1990-08-03 Recombinant adenovirus sequence expressing rhabdovirus antigen and use as a vaccine
CN90107300.8A CN1050561A (en) 1989-08-22 1990-08-22 Recombinant dna order, express the recombinant adenovirus of this DNA sequence and contain the rhabdovirus vaccine of this recombinant adenovirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898919102A GB8919102D0 (en) 1989-08-22 1989-08-22 A recombinant adenovirus dna sequence,a recombinant adenovirus expressing the dna sequence and a rhabdovirus vaccine including the recombinant adenovirus

Publications (1)

Publication Number Publication Date
GB8919102D0 true GB8919102D0 (en) 1989-10-04

Family

ID=10661965

Family Applications (1)

Application Number Title Priority Date Filing Date
GB898919102A Pending GB8919102D0 (en) 1989-08-22 1989-08-22 A recombinant adenovirus dna sequence,a recombinant adenovirus expressing the dna sequence and a rhabdovirus vaccine including the recombinant adenovirus

Country Status (3)

Country Link
CN (1) CN1050561A (en)
GB (1) GB8919102D0 (en)
WO (1) WO1991002804A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2201055T3 (en) * 1992-08-07 2004-03-16 Wyeth RECOMBINANT ADENOVIRUS VACCINES.
AU7081896A (en) * 1995-10-05 1997-04-28 Microbix Biosystems Inc. Rabies recombinant adenovirus
US6670188B1 (en) * 1998-04-24 2003-12-30 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
CN1310677C (en) * 2004-02-05 2007-04-18 中国农业科学院兰州兽医研究所 Method of preparing rabies live carrier vaccine using gland virus carrier expression rabies virus bigene
CN1718242A (en) * 2004-07-07 2006-01-11 中国人民解放军军事医学科学院军事兽医研究所 The canine adenovirus type 2 recombiant vaccine of rabies virus sugar/structural protein such as nuclear
US11254711B2 (en) * 2015-06-12 2022-02-22 Glaxosmithkline Biologicals Sa Adenovirus polynucleotides and polypeptides

Also Published As

Publication number Publication date
CN1050561A (en) 1991-04-10
WO1991002804A1 (en) 1991-03-07

Similar Documents

Publication Publication Date Title
AR241939A1 (en) Recombinant avipox virus
IL81839A0 (en) Polypeptide,dna and its use
HUT59177A (en) Stick cement with improved bonding strength
ZA975889B (en) HIV envelope polypeptides and vaccine.
IL90209A0 (en) Dna coding for a hiv-1 protein,the protein produced and its use
GB8821528D0 (en) Recombinant vaccinia virus
NZ224046A (en) Hiv antigenic peptide fragments and their use
GB8823068D0 (en) Recombinant dna
GB2203740B (en) Novel peptides, their preparation and use
EP0274259A3 (en) New renin-inhibitory oligopeptides, their preparaton and their use
NZ229679A (en) Recombinant dna sequence encoding an emeria peptide, the peptide and poultry vaccine against coccidiosis
IL85088A (en) Anti-malarial peptides,their copolymers and vaccines comprising them
GB8919102D0 (en) A recombinant adenovirus dna sequence,a recombinant adenovirus expressing the dna sequence and a rhabdovirus vaccine including the recombinant adenovirus
DK575787A (en) Recombinant HCMV-derived plasmid, its preparation and use
DK698188D0 (en) PEPTIDES, THEIR PREPARATION AND USE
GB2282601B (en) Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
ZA907656B (en) A dna sequence,an anther-specific promoter and the use thereof
GB8929110D0 (en) Polypeptides and dna encoding therefor
IL96647A0 (en) Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
ZA902205B (en) Binders,their preparation and use in curable mixtures
ZA871433B (en) Benzoylphenylureas,the preparation thereof and the use thereof in pest control
ZA889506B (en) Soluble recombinant fce-receptor,the preparation and the use thereof
GB8915870D0 (en) Dna coding for a polypeptide signal sequence in vaccinia virus
GB9423663D0 (en) Viral preparations, immunogens, and vaccines
IE870674L (en) Polypeptide, dna and its use